This announcement is a separate document:
派林生物：监事会关于2020年股票期权与限制性股票激励计划相关价格调整的核查意见
Pailin Biotech: Supervisory Board\'s Review Opinions on Price Adjustments Related to 2020 Stock Options and Restricted Stock Incentive Plans
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.